Related Experiment Video
Updated: Aug 2, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
Transduction of human hepatocellular carcinoma cells with human alpha-interferon gene via retroviral vector
Abstract:
AIM:To investigate the therapeutic potential of gamma interferon (IFN-alpha) genemodified human hepatocellular carcinoma (HCC) cells.METHODS:The IFN-alpha gene was introduced retrovirally into four HCC cell lines.Secreted IFN-alpha activity was assessed using bioassay. The expression of MHC molecules was detected by FACS.Tumorigenicity was analysed by tumor formation in nude mice.RESULTS:Four IFN-alpha gene transduced HCC cell lines secreted different amounts of IFN-alpha, as in the same case of five clones derived from one HCC cell line. Transduction with IFN-alpha caused significant increase in the expression of major histocompatibility complex (MHC) antigens on HCC cells. The expression of HLA class I was increased by 2-3 times in terms of mean fluorescence intensities, while for class II expression, the percentage of positive cells augmented from < 10% to &lg 50%. When equal amount of tumor cells were injected into nude mice, the tumor igenicity some transduced cells decreased dramantically.CONCLUSION:IFN-alpha gene transduction can convert weakly imunogenic HCC cells to activate antitumor immune response, and further pave the way for the future use of such gene modified tumor cells as a modality for the cancer immunotherapy.
Insights
Genetically modifying liver cancer cells with interferon-alpha (IFN-alpha) enhanced their immune recognition and reduced tumor growth in mice. This approach shows promise for developing novel cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Gene Therapy
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Developing effective cancer immunotherapies remains a critical challenge.
Purpose of the Study:
- To explore the therapeutic potential of genetically modified human hepatocellular carcinoma (HCC) cells using interferon-alpha (IFN-alpha).
- To assess the impact of IFN-alpha gene transduction on HCC cell immunogenicity and tumorigenicity.
Main Methods:
- Retroviral introduction of the IFN-alpha gene into four HCC cell lines.
- Assessment of secreted IFN-alpha activity via bioassay.
- Detection of major histocompatibility complex (MHC) molecule expression using flow cytometry (FACS).
- Analysis of tumor formation in nude mice to evaluate tumorigenicity.
Main Results:
- Transduced HCC cell lines secreted varying levels of IFN-alpha.
- IFN-alpha gene transduction significantly increased MHC antigen expression on HCC cells, including HLA class I and II.
- Tumorigenicity of modified HCC cells was dramatically reduced in nude mice.
Conclusions:
- IFN-alpha gene transduction can transform weakly immunogenic HCC cells into ones that activate an antitumor immune response.
- This strategy offers a potential new avenue for cancer immunotherapy using genetically modified tumor cells.
More Related Videos
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Hepatitis
Inhibitors of Viral Protein Synthesis

